UPDATED Mar 08, 2024
Highly cyclical companies in construction-related industries with a strong future outlook.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MARKSANSMarksans Pharma | ₹149.55 | -4.4% | 117.5% | ₹67.8b | n/a | PE21.4x | E20.6% | 0.3% | ||
524735Hikal | ₹276.30 | -0.8% | -6.7% | ₹34.1b | ₹330.00 | PE47.6x | E37.7% | 0.4% | ||
ORCHPHARMAOrchid Pharma | ₹1,077.55 | -8.3% | 158.8% | ₹54.7b | ₹1,130.00 | PE43.9x | E41.2% | n/a | ||
LAURUSLABSLaurus Labs | ₹422.00 | 3.0% | 36.7% | ₹227.4b | ₹369.31 | PE121x | E49.3% | 0.4% |